Literature DB >> 16687148

A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia.

Claudio Priore Oliva, Patrizia Tarugi, Sebastiano Calandra, Livia Pisciotta, Antonella Bellocchio, Stefano Bertolini, Ornella Guardamagna, Frank G Schaap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16687148     DOI： 10.1016/j.atherosclerosis.2006.04.010

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  10 in total

1.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

2.  Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.

Authors:  Ferenc Hadarits; Péter Kisfali; Márton Mohás; Anita Maász; Balázs Duga; Ingrid Janicsek; István Wittmann; Béla Melegh
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

3.  Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.

Authors:  Xiao Shu; Lisa Nelbach; Michael M Weinstein; Braydon L Burgess; Jennifer A Beckstead; Stephen G Young; Robert O Ryan; Trudy M Forte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-21       Impact factor: 8.311

4.  Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.

Authors:  P Hahne; F Krempler; F G Schaap; S M Soyal; H Höffinger; K Miller; H Oberkofler; W Strobl; W Patsch
Journal:  J Intern Med       Date:  2008-06-03       Impact factor: 8.989

Review 5.  Apoprotein A-V: an important regulator of triglyceride metabolism.

Authors:  M Kluger; J Heeren; M Merkel
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

6.  Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.

Authors:  Angelo B Cefalù; Davide Noto; Maria Luisa Arpi; Fen Yin; Rossella Spina; Hannele Hilden; Carlo M Barbagallo; Antonio Carroccio; Patrizia Tarugi; Sebastiano Squatrito; Riccardo Vigneri; Marja-Riitta Taskinen; Miklós Péterfy; Maurizio R Averna
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

7.  Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.

Authors:  Anfal A Jasim; Suzanne A Al-Bustan; Wafa Al-Kandari; Ahmad Al-Serri; Huda AlAskar
Journal:  Front Genet       Date:  2018-04-09       Impact factor: 4.599

8.  APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.

Authors:  Catalina Dussaillant; Valentina Serrano; Alberto Maiz; Susana Eyheramendy; Luis Rodrigo Cataldo; Matías Chavez; Susan V Smalley; Marcela Fuentes; Attilio Rigotti; Lorena Rubio; Carlos F Lagos; José Alfredo Martinez; José Luis Santos
Journal:  BMC Med Genet       Date:  2012-11-15       Impact factor: 2.103

Review 9.  Apolipoprotein A-V gene therapy for disease prevention / treatment: a critical analysis.

Authors:  Trudy M Forte; Vineeta Sharma; Robert O Ryan
Journal:  J Biomed Res       Date:  2015-10-20

10.  Very Severe Hypertriglyceridemia in a Large US County Health Care System: Associated Conditions and Management.

Authors:  Maria Isabel Esparza; Xilong Li; Beverley Adams-Huet; Chandna Vasandani; Amy Vora; Sandeep R Das; Abhimanyu Garg; Zahid Ahmad
Journal:  J Endocr Soc       Date:  2019-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.